Amylyx Pharmaceuticals Inc (AMLX)
25.06
-0.94 (-3.62%)
USD |
NASDAQ |
Aug 12, 16:00
25.06
0.00 (0.00%)
After-Hours: 17:08
Amylyx Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
Turning Point Therapeutics Inc | 109.19M |
Bristol-Myers Squibb Co | -769.00M |
Alnylam Pharmaceuticals Inc | -506.30M |
Immunogen Inc | -1.008M |
Omeros Corp | 78.24M |